MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • MDS Virtual Congress 2020

    Prevalence of Neuropsychiatric Symptoms in the Prodromal Stages of Dementia with Lewy Bodies and Parkinson’s Disease Dementia

    K. Wyman-Chick, L. Erickson, D. Weintraub, M. Rosenbloom, T. Barclay, M. Barrett (St Paul, MN, USA)

    Objective: Investigate neuropsychiatric features of prodromal stage dementia among individuals diagnosed with Lewy body disease. Background: There has been minimal investigation into the prodromal features…
  • MDS Virtual Congress 2020

    Pareidolias and Cognition in Isolated REM Sleep Behavior Disorder

    L. Honeycutt, J.F Gagnon, A. Pelletier, J. De Roy, J. Montplaisir, R. Postuma (Montreal, QC, Canada)

    Objective: The objective of this study is to investigate the relationship between errors on the pareidolia test and global cognition in patients with REM sleep…
  • MDS Virtual Congress 2020

    Behavioral and Psychological Symptoms in Patients with Movement Disorders

    M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)

    Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…
  • MDS Virtual Congress 2020

    α-Synuclein propagation via olfactory pathway induces olfactory bulb atrophy and widespread glucose hypometabolism in a non-human primate model

    M. Sawamura, H. Onoe, H. Tsukada, K. Isa, N. Uemura, T. Isa, R. Takahashi (Kyoto, Japan)

    Objective: We investigated how α-synuclein (α-Syn) pathology spreads from the olfactory bulb (OB) and how the pathology affects brain structure and activity. Background: Parkinson's disease…
  • MDS Virtual Congress 2020

    Magnetic Property Characterization of Deep Gray Matters in Patients with Alzheimer’s diseases, Dementia with Lewy Bodies and Parkinson’s Disease Dementia using Quantitative Susceptibility Mapping

    J. Kim, K. Lee, S. Yoo, Y. Oh, S. Koh (Seoul, Republic of Korea)

    Objective: The purpose of this study was to characterize magnetic properties of deep gray matters in Alzheimer's diseases (AD), dementia with Lewy bodies (DLB) and…
  • MDS Virtual Congress 2020

    Retinal thinning and disease worsening in Lewy body diseases

    A. Murueta-Goyena, R. Del Pino, M. Galdós, B. Arana, M. Acera, MM. Carmona-Abellán, P. Reyero, B. Tijero, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To assess longitudinal changes of retinal thickness measurements and their role as biomarkers of disease progression in patients with Lewy body diseases (LBDs). Background:…
  • MDS Virtual Congress 2020

    Predictors of the progression of dementia with Lewy bodies

    A. Chimagomedova, O. Levin (Moscow, Russian Federation)

    Objective: To define predictors of the progression of dementia with Lewy bodies (DLB). Background: Dementia with Lewy bodies is a progressive disabling neurodegenerative disease with…
  • MDS Virtual Congress 2020

    Comparison of 123I-MIBG myocardial scintigraphy and 123I-FP-CIT SPECT between dementia with Lewy bodies and Parkinson’s disease

    Y. Asahara, S. Miyagawa, M. Suzuki (Tokyo, Japan)

    Objective: ​​​​​The objective of this study was to compare the nuclear medicine images of dementia with Lewy bodies (DLB) ​​and Parkinson's disease (PD) patients and to extract findings…
  • 2019 International Congress

    An Informant-based Simple Questionnaire for Executive Function Assessment in Dementia with Lewy Bodies and Alzheimer’s Disease

    YS. Liang, GU. Hung, CY. Wei, PY. Chiu (Changhua, Taiwan)

    Objective: The aim of this study was to investigate and compare executive dysfunction by using a newly designed informant-based simple questionnaire among patients with DLB…
  • 2019 International Congress

    Efficacy and safety of zonisamide in patients with dementia with Lewy bodies with parkinsonism: pooled analysis of phase 2 and 3 trials

    J. Goldman, K. Hasegawa, T. Odawara, K. Kochi, H. Maruyama, O. Konishi, S. Toya, K. Kosaka, M. Murata, I. Mckeith (Chicago, IL, USA)

    Objective: To characterize the efficacy and safety of zonisamide (ZNS) in patients with dementia with Lewy bodies (DLB) with parkinsonism, a pooled analysis of two…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley